Atherosclerosis in primary antiphospholipid syndrome

Paul R J Ames, Giovanna Scenna, Iolanda Antinolfi, Luis Lopez, Luigi Iannaccone, Eiji Matsuura, Annamaria Margarita

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Antiphospholipid syndrome (APS) is the most common cause of acquired thrombophilia, but experimental and clinical evidence accumulated over the years suggest that the clinical manifestations of APS go beyond those of a simple hypercoagulable state. Although still a controversial topic, the elevated risk of atherosclerosis in systemic lupus erythematosus seems little accounted for by the presence of antiphospholipid antibodies, whereas premature atherosclerosis has been addressed in few series of patients with primary APS. The available data in primary APS suggest that traditional risk factors for atherosclerosis are less involved in arterial disease, rather antiphospholipid antibodies appear as major players. Their effect on the coagulation system, the vessel wall and on the antioxidant/oxidant balance impairs vascular homeostasis, leading to premature arterial thickening.

Original languageEnglish
Pages (from-to)53-60
Number of pages8
JournalExpert Review of Clinical Immunology
Volume4
Issue number1
DOIs
Publication statusPublished - Jan 2008

Fingerprint

Antiphospholipid Syndrome
Atherosclerosis
Antiphospholipid Antibodies
Thrombophilia
Oxidants
Systemic Lupus Erythematosus
Blood Vessels
Homeostasis
Antioxidants

Keywords

  • β-2-glycoprotein-1
  • Antiphospholipid syndrome
  • Atherosclerosis
  • Oxidation
  • Paraoxonase

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Ames, P. R. J., Scenna, G., Antinolfi, I., Lopez, L., Iannaccone, L., Matsuura, E., & Margarita, A. (2008). Atherosclerosis in primary antiphospholipid syndrome. Expert Review of Clinical Immunology, 4(1), 53-60. https://doi.org/10.1586/1744666X.4.1.53

Atherosclerosis in primary antiphospholipid syndrome. / Ames, Paul R J; Scenna, Giovanna; Antinolfi, Iolanda; Lopez, Luis; Iannaccone, Luigi; Matsuura, Eiji; Margarita, Annamaria.

In: Expert Review of Clinical Immunology, Vol. 4, No. 1, 01.2008, p. 53-60.

Research output: Contribution to journalArticle

Ames, PRJ, Scenna, G, Antinolfi, I, Lopez, L, Iannaccone, L, Matsuura, E & Margarita, A 2008, 'Atherosclerosis in primary antiphospholipid syndrome', Expert Review of Clinical Immunology, vol. 4, no. 1, pp. 53-60. https://doi.org/10.1586/1744666X.4.1.53
Ames, Paul R J ; Scenna, Giovanna ; Antinolfi, Iolanda ; Lopez, Luis ; Iannaccone, Luigi ; Matsuura, Eiji ; Margarita, Annamaria. / Atherosclerosis in primary antiphospholipid syndrome. In: Expert Review of Clinical Immunology. 2008 ; Vol. 4, No. 1. pp. 53-60.
@article{6652762f7b2c4c0da62aed9deb81f5c3,
title = "Atherosclerosis in primary antiphospholipid syndrome",
abstract = "Antiphospholipid syndrome (APS) is the most common cause of acquired thrombophilia, but experimental and clinical evidence accumulated over the years suggest that the clinical manifestations of APS go beyond those of a simple hypercoagulable state. Although still a controversial topic, the elevated risk of atherosclerosis in systemic lupus erythematosus seems little accounted for by the presence of antiphospholipid antibodies, whereas premature atherosclerosis has been addressed in few series of patients with primary APS. The available data in primary APS suggest that traditional risk factors for atherosclerosis are less involved in arterial disease, rather antiphospholipid antibodies appear as major players. Their effect on the coagulation system, the vessel wall and on the antioxidant/oxidant balance impairs vascular homeostasis, leading to premature arterial thickening.",
keywords = "β-2-glycoprotein-1, Antiphospholipid syndrome, Atherosclerosis, Oxidation, Paraoxonase",
author = "Ames, {Paul R J} and Giovanna Scenna and Iolanda Antinolfi and Luis Lopez and Luigi Iannaccone and Eiji Matsuura and Annamaria Margarita",
year = "2008",
month = "1",
doi = "10.1586/1744666X.4.1.53",
language = "English",
volume = "4",
pages = "53--60",
journal = "Expert Review of Clinical Immunology",
issn = "1744-666X",
publisher = "Expert Reviews Ltd.",
number = "1",

}

TY - JOUR

T1 - Atherosclerosis in primary antiphospholipid syndrome

AU - Ames, Paul R J

AU - Scenna, Giovanna

AU - Antinolfi, Iolanda

AU - Lopez, Luis

AU - Iannaccone, Luigi

AU - Matsuura, Eiji

AU - Margarita, Annamaria

PY - 2008/1

Y1 - 2008/1

N2 - Antiphospholipid syndrome (APS) is the most common cause of acquired thrombophilia, but experimental and clinical evidence accumulated over the years suggest that the clinical manifestations of APS go beyond those of a simple hypercoagulable state. Although still a controversial topic, the elevated risk of atherosclerosis in systemic lupus erythematosus seems little accounted for by the presence of antiphospholipid antibodies, whereas premature atherosclerosis has been addressed in few series of patients with primary APS. The available data in primary APS suggest that traditional risk factors for atherosclerosis are less involved in arterial disease, rather antiphospholipid antibodies appear as major players. Their effect on the coagulation system, the vessel wall and on the antioxidant/oxidant balance impairs vascular homeostasis, leading to premature arterial thickening.

AB - Antiphospholipid syndrome (APS) is the most common cause of acquired thrombophilia, but experimental and clinical evidence accumulated over the years suggest that the clinical manifestations of APS go beyond those of a simple hypercoagulable state. Although still a controversial topic, the elevated risk of atherosclerosis in systemic lupus erythematosus seems little accounted for by the presence of antiphospholipid antibodies, whereas premature atherosclerosis has been addressed in few series of patients with primary APS. The available data in primary APS suggest that traditional risk factors for atherosclerosis are less involved in arterial disease, rather antiphospholipid antibodies appear as major players. Their effect on the coagulation system, the vessel wall and on the antioxidant/oxidant balance impairs vascular homeostasis, leading to premature arterial thickening.

KW - β-2-glycoprotein-1

KW - Antiphospholipid syndrome

KW - Atherosclerosis

KW - Oxidation

KW - Paraoxonase

UR - http://www.scopus.com/inward/record.url?scp=46149121781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46149121781&partnerID=8YFLogxK

U2 - 10.1586/1744666X.4.1.53

DO - 10.1586/1744666X.4.1.53

M3 - Article

C2 - 20477587

AN - SCOPUS:46149121781

VL - 4

SP - 53

EP - 60

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

SN - 1744-666X

IS - 1

ER -